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The Candida antigen CR3-RP (complement receptor 3-related protein) is supposed to be a
‘mimicry’ protein because of its ability to bind antibody directed against the a subunit of the
mammalian CR3 (CD11b/CD18). This study aimed to (i) investigate the specific humoral isotypic
response to immunization with CR3-RP in vivo in a rabbit animal model, and (ii) determine the role
of CR3-RP in the adherence of Candida albicans in vitro using the model systems of buccal
epithelial cells (BECs) and biofilm formation. The synthetic C. albicans peptide DINGGGATLPQ
corresponding to 11 amino-acids of the CR3-RP sequence DINGGGATLPQALXQITGVIT,
determined by N-terminal sequencing, was used for immunization of rabbits to obtain polyclonal
anti-CR3-PR serum and for subsequent characterization of the humoral isotypic response of
rabbits. A significant increase of IgG, IgA and IgM anti-CR3-RP specific antibodies was observed
after the third (P,0.01) and the fourth (P,0.001) immunization doses. The elevation of IgA levels
suggested peptide immunomodulation of the IgA1 subclass, presumably in coincidence with
Candida epithelial adherence. Blocking CR3-RP with polyclonal anti-CR3-RP serum reduced the
ability of Candida to adhere to BECs, in comparison with the control, by up to 35% (P,0.001),
and reduced biofilm formation by 28% (P,0.001), including changes in biofilm thickness and
integrity detected by confocal laser scanning microscopy. These properties of CR3-RP suggest
that it has potential for future vaccine development.
INTRODUCTION
Candida albicans is the most frequently isolated fungal
pathogen associated with infection of immunocompro-
mised patients in hospital settings. The high propensity to
cause disease is due to the expression of many virulence
factors including highly immunogenic cell surface proteins
(Alberti-Segui et al., 2004; Jeng et al., 2005; Pietrella et al.,
2006) able to trigger cellular and humoral response (Viudes
et al., 2001; Lo´pez-Ribot et al., 2004; Omaetxebarria et al.,
2005; Fukuizumi et al., 2006). Additionally, a variety of cell
surface molecules expressed by Candida help it to evade the
host immune response by mimicry of host receptors
(Gustafson et al., 1991; Phan et al., 2007). The receptor
MAC-1 (CD11b/CD18) on lymphocytes is the surface b2
integrin that mediates lymphocyte adhesion to C. albicans
(Forsyth & Mathews, 2002). However, Candida is not only
the target for MAC-1, but also CR3-RP identified on the
yeast surface might be classified as a member of the
integrin family due to its antigenic, structural and
functional relation to the a subunit of the mammalian
neutrophil receptor CD11b/CD18 (Gilmore et al., 1988;
Abbreviations: BEC, buccal epithelial cell; CLSM, confocal laser
scanning microscopy; RT, room temperature; XTT, 2,3-bis(2-methoxy-
4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide.
The GenBank/EMBL/DDBJ accession number for the N-terminal
sequence fragment of CR3-RP is P85437.
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Hostetter et al., 1990; Hostetter, 1996). Binding the human
complement fragment iC3b to this receptor results in
inhibition of opsonization and partial blocking of pha-
gocytosis (Hostetter et al., 1984; Heidenreich & Dierich,
1985). Several putative fragments of CR3-RP have been
reported: these include a 165 kDa fragment (Hostetter et al.,
1990), 66, 55 and 42 kDa fragments (Alaei et al., 1993),
and 42 and 32 kDa fragments (Bujda´kova´ et al., 1999).
Furthermore, a gene encoding a 188 kDa integrin with
18 % homology to the human CR3 has also been
described in C. albicans (Gale et al., 1996). Recently, the
effect of oestrogen on CR3-RP expression was studied
(Warolin et al., 2005). Others reported that the
transcription of CR3-RP was found to be dependent on
Ca2+ ions and the yeast–mycelial transformation; its
expression being higher in germ tubes and in the mycelial
form (Spo¨tl et al., 1994; Bujda´kova´ et al., 1997).
C. albicans is able to bind to collagen, laminin or
fibronectin via special surface molecules (Makihira et al.,
2002; Cateau et al., 2007), and CR3-RP has been reported
to participate in adhesion to endothelial cells (Wu¨rzner
et al., 1996). Adhesion of C. albicans to host cells is a
crucial step in establishment of candidiasis. Moreover, it is
also critical for an early phase in biofilm formation, the
phenomenon associated with the new classes of diseases
correlated with using medical devices (Kojic & Darouiche,
2004). Several genes that code for proteins that enhance the
adherence capacity of C. albicans have been reported
(Ibrahim et al., 2005; Nailis et al., 2006; Nobile et al., 2006).
However, anti-Candida antibodies can reduce Candida
binding to different surfaces (Rodier et al., 2003; Elguezabal
et al., 2004; Lo´pez-Ribot et al., 2004). To that end, the aim
of this study was to (i) investigate the specific humoral
isotypic response to immunization with CR3-RP in vivo in
a rabbit animal model, and (ii) determine the role of CR3-
RP in adherence of C. albicans in vitro using the model
systems of buccal epithelial cells (BECs) and biofilm
formation.
METHODS
Purification and analysis of the 45 kDa protein. The strain C.
albicans K2 (CCY 29-3-162 from the Culture Collection of Yeasts
(CCY), Institute of Chemistry, Slovak Academy of Sciences),
originally isolated from vaginal candidiasis, was selected based on
the high expression of CR3-RP (Bujda´kova´ et al., 1997). Total protein
extract (100 ml) was obtained from 6 l germ tube suspension
(107 germ tubes ml21) by breakage with glass beads (diameter
2 mm; Sigma-Aldrich) in breaking buffer (20 %, v/v, glycerol;
0.1 M Tris/HCl, pH 8.0; 1 mM DTT; 1 mM PMSF; all from Sigma-
Aldrich). Germ-tube formation was induced as described previously
(Bujda´kova´ et al., 1997). Briefly, an overnight yeast culture of C.
albicans grown in yeast peptone dextrose (YPD) medium was washed
three times with 0.85 % NaCl, then centrifuged (5000 g, 10 min) and
resuspended in 0.85 % NaCl in a new Falcon tube. This culture was
ready for the starvation phase, which was performed at 28 uC for 2 h
with gentle shaking (120 r.p.m.). Afterwards, the cell suspension was
centrifuged again and adjusted to 107 cells ml21 in RPMI medium
with the addition of 300 mg N-acetylglucosamine l21, and adjusted
with 50 mM Na2HPO4/KH2PO4 (all from Applichem) to pH 7.0.
After 2 h incubation at 37 uC with shaking (180 r.p.m.), almost 95 %
of the C. albicans in yeast form was transformed to germ tube form.
The germ tubes were collected by centrifugation (5000 g, 10 min) and
the sediment was resuspended in 40 ml breaking buffer. Then the
suspension was divided into 1 ml aliquots in 2 ml Eppendorf tubes
and an approximately equal volume of glass beads was added to every
tube. Cells were disrupted by vortexing 40 times at high speed for
1 min. Between vortexing steps, the tubes were cooled in an ice bath
for 15 s. Then broken cells were centrifuged again (10 000 g, 4 uC,
10 min) and the supernatant containing protein extract was collected
and dialysed in 20 mM Tris/HCl (pH 7.5) overnight. Then the extract
was transferred into a new Falcon tube and 1 mM PMSF was added.
An aliquot (4 ml) of the protein extract was stored at 220 uC until
needed and the remaining sample was concentrated by filtration
through an Amicon device (Millipore) to 4 ml. Partial purification of
the 45 kDa protein (Bujda´kova´ et al., 1999) from the protein extract
concentrate was performed by FPLC with Superose 12 P (Amersham)
column (2640 cm) equilibrated with 0.02 M NH4HCO3. Fractions
were separated by SDS-PAGE in a 12.5 % polyacrylamide gel
(Applichem), and the ~45 kDa band was extracted and subjected to
FPLC again. Purified samples were concentrated by a Microcon YM
10 filter (Millipore) to 100 ml volume, and analysed by SDS-PAGE,
followed by blotting to both nitrocellulose and PVDF membranes
(both from Serva). The reaction of the protein with monoclonal
antibody OKM1 (American Type Culture Collection cultures CRL-
8026, recognizing the a chain of human CR3, CD11b) on
nitrocellulose membrane was performed as described previously
(Bujda´kova´ et al., 1999). Briefly, after overnight blocking at 4 uC in
Tris buffered saline (TBS) buffer (50 mM Tris/HCl, pH 7.4; 150 mM
NaCl) supplemented with 5 % (w/v) non-fat dry milk, the membrane
was incubated with the OKM 1 antibody diluted 1 : 40 in TBS for 1 h
at room temperature (RT). After three washing steps in TBS, 0.05 %
(v/v) Tween 20 (Merck) (TBST), anti-rabbit IgG conjugated with
alkaline phosphatase (Sigma-Aldrich) diluted 1 : 30 000 in TBS was
added. The membrane was incubated for 1 h at RT. After four washes
in TBST, the membrane was developed using Sigma Fast BCIP/NBT
tablet (Sigma-Aldrich) dissolved in 10 ml deionized water. The colour
reaction was stopped with deionized water.
The PVDF membrane was stained with amido black solution
(Applichem) and subjected to N-terminal sequencing in two
laboratories independently: at Innsbruck Medical University, where
11 amino acids were sequenced, and at the Institute of Organic
Chemistry and Biochemistry, Academy of Sciences of the Czech
Republic, where 21 amino acids were identified by Edman
degradation on an ABI 491 protein sequencer.
Preparation of polyclonal antibody to CR3-RP, ELISA and
Western blotting. A synthetic peptide with .90 % purity, as
revealed by HPLC and MS analysis, was generated by KJ Ross-
Petersen, Denmark. Its sequence corresponded to the first 11 amino
acid residues (DINGGGATLPQ) at the N-terminus of the CR3-RP
protein. This peptide was used to raise polyclonal anti-CR3-RP serum
by immunization of rabbits (female, 8-weeks-old, 2250 g weight,
variety Hyla; Research Institute of Animal Production, Nitra,
Slovakia). The rabbits were split in two groups of three each. Pre-
immune serum samples were collected as a negative control before the
experiment. The two groups were immunized by: (i) an intramuscular
injection of 40 mg CR3-RP mixed with complete Freund’s adjuvant
(Sigma-Aldrich) at day 0, boosted with another four doses in
incomplete Freund’s adjuvant (80 mg, 160 mg, 300 mg, 300 mg) 2
weeks apart (five immunizations in total); or (ii) heat inactivated
Candida yeast-form cell suspension in sterile saline (107 ml21)
administered intravenously in a marginal ear vein three times, 2
weeks apart. Both groups of rabbits were bled 2 weeks after the last
injection. Antibody titres were determined by ELISA in 96-well plates
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(Sarstedt) (Voller, 1978). The wells were coated with 100 ml (per well)
CR3-RP diluted in PBS at final concentration 5 mg ml21, supple-
mented with 100 ml coating buffer (0.1 M NaHCO3, pH 9.6), and
incubated overnight at 4 uC. After one washing step, non-specific
binding was blocked by 1 h incubation in 3 % (w/v) non-fat dry milk
(Merck) in PBS, 0.05 % (v/v) Tween 20 (Sigma-Aldrich) (PBST). The
peptide was incubated with several dilutions of the anti-CR3-RP
serum. After three washing steps with PBST, goat anti-rabbit IgG
conjugated with alkaline phosphatase (Sigma-Aldrich) diluted
1 : 30 000 was added and the plate was incubated for 1 h at RT.
After four additional washing steps, alkaline phosphatase substrate
containing p-nitrophenylphosphate (Sigma-Aldrich) was used for
developing the results. The reaction was stopped with 3 M NaOH and
the absorbance measured at 490 nm using a microplate reader (MRX;
Dynex). For immunoblotting, 15 ml C. albicans K2 protein extract was
separated by 12.5 % SDS-PAGE and transferred to nitrocellulose
membrane (Serva). After overnight blocking at 4 uC in TBS buffer
supplemented with 5 % (w/v) non-fat dry milk, the membrane was
incubated with the polyclonal anti-CR3-RP serum (diluted 1 : 100 in
TBS) for 1 h at RT. After three washing steps in TBST, anti-rabbit IgG
conjugated with alkaline phosphatase (Sigma-Aldrich) diluted
1 : 30 000 in TBS was added. The membrane was incubated for 1 h
at RT. After four washes in TBST, the membrane was developed using
SigmaFast BCIP/NBT tablets (Sigma-Aldrich) dissolved in deionized
water (10 ml per tablet). The colour reaction was stopped with
deionized water.
Production of CR3-RP specific IgG, IgM and IgA antibodies in a
rabbit model, and ELISA. The CR3-RP specific rabbit IgG, IgM and
IgA isotype antibodies induced by immunization with either CR3-RP
in Freund’s adjuvant or whole Candida cells were detected using a
modified ELISA. Briefly, 10 mg CR3-RP in carbonate/bicarbonate
buffer pH 9.6 (100 ml per well) was applied onto Immulon 4 HBX
microplates (Dynex) for 18 h at 4 uC, and the plates were coated with
2 % (w/v) non-fat milk (KPL) in PBST pH 7.2. Sequential titrations
of rabbit antisera were performed stepwise with the pre-coated CR3-
RP overnight at 4 uC. Immune complexes were tested for alkaline
phosphatase-labelled protein A (Calbiochem) for IgG, and with
alkaline phosphatase-labelled goat anti-rabbit IgA and IgM (Bethyl
Laboratories) for antisera IgA and IgM levels, respectively. The
enzyme reaction was developed with the BluePhos microwell
phosphatase substrate system (KPL) and absorbance measured at
630 nm (MRX II; Dynex). The results were expressed as arbitrary
units, defined as the amount of the anti-CR3-RP specific IgG, IgA and
IgM present in 1 : 1000 dilution of the reference whole cell antiserum,
and were calculated as a percentage of the reference whole cell
antiserum (100 %) and presented as the mean± SEM of three rabbits
per group.
Computational and statistical analysis. Results from in vitro
experiments were calculated as mean values±SEM. Similarly, in vivo
results were expressed as the mean±SEM for each examined group.
Normality of distribution was evaluated according to the Shapiro–
Wilk test at the 0.05 level of significance. Statistical comparison
between groups was performed using one-way analysis of variance
(ANOVA) and post-hoc Bonferroni and Tukey tests. The results were
significant if the difference between the analysed groups equalled or
exceeded the 95 % confidence level (P,0.05). Analyses were
performed using Origin 7.5 Pro software (OriginLab).
Adherence to BECs. Adherence of Candida cells, with and without
pre-incubation with the polyclonal anti-CR3-RP serum, to BECs was
performed according to Moragues et al. (2003) with some modifica-
tions. Briefly, human BECs were collected from six healthy volunteers
by gently scraping cheek mucosa with sterile wooden spatulas. After
centrifugation (1000 g, 10 min, RT), the cells were washed three times
with PBS and suspended at 105 cells ml21 in PBS. C. albicans cells
from an overnight culture in YPD were washed with PBS three times
and diluted in PBS to a density of 108 cells ml21. For testing the
polyclonal anti-CR3-RP serum, 100 ml Candida suspension was
harvested by centrifugation at 2000 g for 5 min at 4 uC, and washed
gently three times with 500 ml blocking solution (3 % gelatin in PBS).
Then, 50 ml polyclonal anti-CR3-RP serum diluted 1 : 100 in PBS was
mixed with Candida cells and incubated on ice for 1 h. This
suspension was washed three times with PBST, collected and used
directly for incubation with BECs. In the control experiment, Candida
cells were treated only with PBS instead of polyclonal anti-CR3-RP
serum. The 500 ml BEC suspension was mixed with 50 ml Candida
suspension treated with polyclonal anti-CR3-RP serum or PBS and
incubated for 2 h with gentle agitation (100 r.p.m.) at 37 uC. The
mixtures were centrifuged (1000 g, 10 min, RT), the supernatants
discarded and the pellets resuspended in 50 ml PBS by gentle rotary
mixing. The cells were then counted with a haemocytometer. A
minimum of 100 BECs were analyzed using light microscopy at 4006
magnification to determine the number of adherent Candida cells.
The number of adherent yeast upon pretreatment with specific
antibody and pre-immune serum was calculated as a percentage of
those pretreated with PBS in the parallel control experiment (100 %).
The final percentage of adherent cells was determined as the
difference between the percentage of Candida cells treated with
polyclonal anti-CR3 serum and those treated with pre-immune
serum. For capturing an image, the suspension of BECs with Candida
cells was dropped onto a glass slide, dried at RT, and then fixed with
methanol for 10 s, covered with 5 ml crystal violet and dried again at
RT (Fig. 1).
Determination of cell surface hydrophobicity (CSH) and biofilm
formation. Yeast C. albicans K2 used for both hydrophobicity and
biofilm assays was cultivated on Sabouraud dextrose agar (Biomark
Laboratories) at 28 uC for 24 h. A large loop of cells was transferred
into yeast nitrogen base with amino acids (YNB) broth (Sigma-
Aldrich) supplemented with 0.9 % D-glucose (Applichem), and after
overnight incubation at 37 uC, the cells were centrifuged at 4000 g for
5 min and washed twice with 0.5 ml PBS. The cells were resuspended
in 1.5 ml YNB broth and the suspension was adjusted to OD600 1.0.
CSH was measured according to the method of Klotz et al. (1985)
using the biphasic separation method with n-octan (Merck) overlay.
Unattached C. albicans
Adherent C. albicans
BEC
100 mm
Fig. 1. Binding of C. albicans yeast cells to human BECs
visualized by crystal violet staining. Arrows indicate adherent, as
well as non-adherent C. albicans and BECs.
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The relative percentage of CSH was calculated as follows: [(OD600 of
the control2OD600 after octane overlay)/OD600 of the control]6100.
Biofilm was formed using polystyrene 96-well plates (Sarstedt) in
100 ml YNB medium supplemented with 0.9 % D-glucose at 37 uC
and quantified by its ability to reduce XTT [2,3-bis(2-methoxy-4-
nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide] sodium salt to
water soluble formazan (Sigma-Aldrich) as described by Li et al.
(2003). Parallel experiments were performed with pre-incubation of
C. albicans cells with polyclonal anti-CR3-RP serum and pre-immune
serum. The yeast suspension prepared as described above, was
centrifuged, the cell pellet treated by three washes in 3 % (w/v) gelatin
(Oxoid) dissolved in PBS, and then incubated with 50 ml polyclonal
anti-CR3-RP serum or pre-immune serum, both diluted 1 : 100 in
PBS, for 1 h on ice. Serum was removed by centrifugation and three
washes in PBST and the yeast cells were used for the hydrophobicity
and biofilm assays.
Confocal laser scanning microscopy (CLSM). Mature biofilms
formed on polyethylene coverslips in Petri dishes (both from
Sarstedt), prepared according to Li et al. (2003), were transferred to
new Petri dishes and 20 ml tetramethyl rhodamine methyl ester
perchlorate (TMRM; excitation wavelength 549 nm, emission wave-
length 573 nm; Invitrogen), diluted in distilled deionized water to
final concentration of 5 mM, was applied to each coverslip. Stained
biofilms were observed with a LSM 510 META confocal laser
scanning microscope head, mounted on an Axiovert 200 M inverted
microscope (both from Carl Zeiss, Germany). In fluorescence mode,
the 543 nm line of the He–Ne laser excited the sample and a 545 nm
dichroic mirror with 565–615 nm band-pass emission filter were used
for fluorescence detection. In transmission mode the laser light at
543 nm passing through the sample was detected by a photodiode
attached to the microscope condenser. A 2060.75 PlanApochromat
dry objective was used, with the confocal pinhole opening
corresponding to 1 Airy unit. The half-width of the estimated
point-spread function in Z direction was 1.8–2 mm (in the 500–
600 nm wavelength range), therefore we used 0.9 mm Z-axis sampling
for three-dimensional (3D) data recording. For each image,
1536153 mm area was scanned with a resolution of 5126512 pixels,
166 line averaging and 8-bit quantization. The images were further
processed with LSM Image Examiner software. Biofilm images were
either displayed individually as two-dimensional plots, or recon-
structed in 3-D projections. Vertical (xz) sections or side views of the
3D reconstructed images were used to determine biofilm thickness
and architecture. The thickness was estimated from the outer edges of
the area, where TMRM signal gain intensity was above half of its
maximum.
RESULTS AND DISCUSSION
Purification of CR3-RP, and preparation and
evaluation of polyclonal anti-CR3-RP serum
The human CR3, also known as MAC-1 (CD11b/CD18),
expressed on leukocytes is a principal adhesion receptor for
binding iC3b-opsonized pathogens. The existence of
integrin-like proteins in C. albicans with affinity for
complement conversion product iC3b has been suggested
by several authors (Eigentler et al., 1989; Hostetter et al.,
1990; Gustafson et al., 1991; Alaei et al., 1993; Spo¨tl et al.,
1994; Hostetter, 1996; Bujda´kova´ et al., 1999); however,
information about its contribution to Candida virulence is
very limited. C. albicans expressing CR3-RP was able to
form rosettes consisting of iC3b-coated sheep erythrocytes
bound to germ tubes or mycelial forms. Furthermore,
immunofluorescence, as well as ELISA results, revealed
CR3-RP cross-reactivity with anti-human CR3 mAb
named OKM1 (Eigentler et al., 1989; Bujda´kova´ et al.,
1997, 1999), which is able to block the function of the
lectin domain of CD11b. CR3-RP was purified as described
in Methods and the molecular mass was estimated to
be around 45 kDa (Fig. 2). N-terminal sequencing
of the putative CR3-RP protein revealed two amino
acid motifs with sequences DINGGGATLPQ and
DINGGGATLPQALXQITGVIT (the latter sequence was
submitted to the UniProt Knowledgebase, under UniProt
accession number P85437, entitled CR3-RP in C. albicans).
The first 11 amino acids exhibited 100 % homology
between the protein samples sequenced independently in
two different laboratories. This identical sequence was used
to search the Swiss-Prot protein database using BLAST
available online, but revealed no homology to any
Candida proteins or other fungal proteins already pub-
lished. The sequence corresponding to the first 11 amino
acids was synthesized and this peptide was used for
immunization of rabbits as described in Methods.
Immunization of rabbits with CR3-RP and
characterization of the humoral response
We hypothesized that CR3-RP, as further characterized in
this study, belongs to the group of surface molecules
adopted by pathogenic micro-organisms to improve entry
into the host (Sturtevant & Calderone, 1997; Taborda &
Casadevall, 2002; Nosanchuk et al., 2003). These antigens
are usually mannoproteins able to elicit a response from
the host immune system. Successful anti-Candida defence
requires tight cooperation of the different mechanisms of
innate and adaptive immune responses (Roeder et al.,
2004; Netea et al., 2006). In spite of fact that cell-mediated
Fig. 2. (a) SDS-PAGE separation of Candida protein extract after
liquid chromatography visualized by silver staining assay. (b) The
interaction of the CR3-RP blotted to nitrocellulose membrane with
polyclonal anti-CR3-RP serum visualized by alkaline phosphatase
assay. M, Protein size marker; S, sample.
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immunity is important during the first contact with fungal
pathogen, the contribution of the specific humoral
response has also been demonstrated in recent years
(Lo´pez-Ribot et al., 2004; Cutler, 2005; Paulovicˇova´ et al.,
2005). The induction of an antigen-specific humoral
response was evaluated by IgG, IgM and IgA anti-CR3-
RP specific sera levels in immunized rabbits (Fig. 3). While
IgM is the first antibody produced in the humoral
response, mediating opsonization of micro-organisms by
activation of the classical complement pathway, the IgG
class has a protective role, including reduction of the C.
albicans binding capacity to host and medical devices
(Kondori et al., 2003; Rodier et al., 2003), and serum IgA,
mainly its subclass unit antibody, is an important part of
mucosal immunity initiating numerous host defence
activities, such as phagocytosis, cytotoxicity and respiratory
burst (Morton et al., 1996; van Spriel et al., 2002). The
experimental sera were evaluated by ELISA and the isotypic
distribution induced by CR3-RP alone and/or heat-
inactivated whole Candida cells was determined. The
prime–boost immunization strategy enhanced, in particular,
polyclonal production of CR3-RP–specific IgG, IgA and IgM
isotype antibodies. CR3-RP administration induced the
highest increase of anti-CR3-RP IgG and IgA levels after the
third (P,0.01) and later (P,0.001) immunization doses.
Comparison of induced specific anti-CR3-RP-isotypes with
the results from whole Candida cells, especially after the
second booster, demonstrated a higher immunogenicity of
CR3-RP. While induction of IgM and IgG antibodies has
been described for many Candida antigens (Rodier et al.,
2003; Torosantucci et al., 2005), the marked elevation of IgA
levels in serum suggested CR3-PR peptide immunomodula-
tion of the IgA1 subclass, presumably in coincidence with
Candida epithelial adherence.
Role of CR3-RP in adherence to BECs and biofilm
formation, determination of CSH, and CLSM
To test the hypothesis about participation of CR3-RP in
adherence, we coated fungal adherence receptors with an
antibody that can reduce the adherence of C. albicans cells
(Moragues et al., 2003; Lo´pez-Ribot et al., 2004). Upon
treatment with the polyclonal anti-CR3-PR serum, the
binding of Candida cells to BECs was reduced up to 35 %
in comparison with the control sample (P,0.001). This
suggested that the polyclonal anti-CRP-PR serum might
also affect biofilm formation – a complex process in which
adherence is a determining factor (Blanco et al., 2006;
Blankenship & Mitchell, 2006). Indeed, we observed a
reduction in biofilm formation, most likely due to a
decreased adherence capacity mediated by blocking CR3-
RP, by about 28 % in comparison with the control
(P,0.001) (Fig. 4). As hydrophobicity of the yeast cell
wall is an important factor affecting adherence to different
substrates (Hazen et al., 2001; Singleton et al., 2005) and is
directly correlated with the surface protein composition,
we investigated how it is affected by CR3-RP. The
percentage of hydrophobic cells decreased after the pre-
incubation of C. albicans with polyclonal anti-CR3-RP
serum from 20.1 to 9.5 % (P,0.001), suggesting that
interaction of the CR3-RP with the antiserum affects the
hydrophobicity status of the Candida population. Hence, a
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change in the ratio of hydrophobic/hydrophilic cells in a
Candida suspension can indirectly affect the capacity of C.
albicans to adhere to BECs or to polystyrene microtitre
plates in the biofilm model. Using CLSM, a corresponding
reduction in biofilm thickness was observed, from 14.5 mm
in the control to 9 mm in the sample pre-incubated with
the polyclonal anti-CR3-RP serum (P,0.05). Moreover, a
loss of biofilm integrity after pre-incubation with poly-
clonal anti-CR3-RP serum was observed (Fig. 5). Taken
together our results provide evidence for the strong
immunomodulatory efficiency of CR3-RP and its contri-
bution to the adherence of C. albicans. These properties
suggest that CR3-RP is a fungal antigen with a potential for
vaccine development.
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